ALNY logo

ALNYAlnylam Pharmaceuticals Inc

$295.02
$2.44
(0.83%)
Pre-Market
Updated: 06:01 AM EDT·Prev Close $292.58
EarningsJul 30
Mkt Cap$38.2B
Vol444.00
Upcoming Earnings: Q2 '26

Reports: Jul 30Pre-Market

Estimated EPS

$1.63

Estimated Rev

$1.32B

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
$1.63
--
--
N/A
Q1 '26
$0.89
$1.51
68.72%
BEAT
Q4 '25
$1.16
$0.82
-29.06%
MISSED
Q3 '25
$0.56
$1.84
228.01%
BEAT
Q2 '25
-$0.54
-$0.51
6.20%
BEAT